Cadrenal Therapeutics Files 8-K
Ticker: CVKD · Form: 8-K · Filed: Aug 5, 2025 · CIK: 1937993
Sentiment: neutral
Topics: 8-K, filing, financials
Related Tickers: CADR
TL;DR
CADR filed an 8-K, reporting 'Other Events' and financials. Details TBD.
AI Summary
Cadrenal Therapeutics, Inc. filed an 8-K on August 5, 2025, reporting "Other Events" and "Financial Statements and Exhibits." The filing does not contain specific details about the nature of these events or financial statements, only that they are being reported.
Why It Matters
This 8-K filing indicates Cadrenal Therapeutics is reporting significant events or financial updates, which could impact investors' understanding of the company's current status.
Risk Assessment
Risk Level: medium — The filing is an 8-K, which typically reports material events, but the lack of specific details in the provided text makes it difficult to assess the immediate impact or risk.
Key Players & Entities
- Cadrenal Therapeutics, Inc. (company) — Registrant
- August 5, 2025 (date) — Date of Report
FAQ
What specific "Other Events" are being reported by Cadrenal Therapeutics, Inc. in this 8-K filing?
The provided text of the 8-K filing does not specify the nature of the "Other Events" being reported.
When was this 8-K filing submitted to the SEC?
This 8-K filing was submitted on August 5, 2025.
What is the principal executive office address for Cadrenal Therapeutics, Inc.?
The principal executive office address is 822 A1A North, Suite 306, Ponte Vedra, Florida 32082.
What is the SEC file number for Cadrenal Therapeutics, Inc.?
The SEC file number for Cadrenal Therapeutics, Inc. is 001-41596.
Does this filing include details on Cadrenal Therapeutics' financial statements?
The filing indicates that "Financial Statements and Exhibits" are being reported, but the specific details of these statements are not included in the provided text.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on August 5, 2025 regarding Cadrenal Therapeutics, Inc. (CVKD).